VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib.
The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib. Blood. 2016 Apr 14; 127(15):1870-80.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
DNA Mutational Analysis
Drug Resistance, Neoplasm
Fusion Proteins, bcr-abl
Humans
Imidazoles
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Mass Spectrometry
Middle Aged
Multivariate Analysis
Mutation
Prognosis
Protein Kinase Inhibitors
Pyridazines
Treatment Outcome
Young Adult
authors with profiles
VICTOR RIVERA